RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of California, San Francisco
Eli Lilly and Company
Yale University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Novartis
Pfizer